Page 3 - Jens Knudsen News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Correction Notice to Press Release Announcing Financial Results For the Fourth Quarter and Full Year 2021 Financial Results and Corporate Update

Correction Notice to Press Release Announcing Financial Results For the Fourth Quarter and Full Year 2021 Financial Results and Corporate Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomThomas pedersenMike beyerChuck padalaJens knudsenCompany contactCarrotize pr communicationsSam brown incExchange commissionAllarity therapeutics incSmerud medical research internationalWall streetAllarity therapeuticsTherapeutics reports fourth quarterFull year

Correction Notice to Press Release Announcing Financial

Cambridge, MA U.S.A. (May 18, 2022) Allarity Therapeutics, Inc. (NASDAQ: ALLR) announced today that its press release issued under the headline “Allarity.

United statesUnited kingdomThomas pedersenMike beyerChuck padalaJens knudsenCompany contactCarrotize pr communicationsSam brown incExchange commissionAllarity therapeutics incSmerud medical research internationalAllarity therapeuticsTherapeutics reports fourth quarterFull yearRecent highlights

Correction Notice to Press Release Announcing Financial Results For the Fourth Quarter and Full Year 2021 Financial Results and Corporate Update

United statesUnited kingdomThomas pedersenMike beyerChuck padalaJens knudsenCompany contactCarrotize pr communicationsSam brown incExchange commissionAllarity therapeutics incSmerud medical research internationalAllarity therapeuticsTherapeutics reports fourth quarterFull yearRecent highlights

Allarity Therapeutics Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250(c)(1)

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

United statesUnited kingdomThomas pedersenChuck padalaJens knudsenCompany contactCarrotize pr communicationsNasdaq hearings panelExchange commissionAllarity therapeutics incSmerud medical research internationalAllarity therapeuticsListing qualifications departmentNasdaq stock marketNasdaq listing ruleAnnual report

Allarity Therapeutics : Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250(c)(1) - Form 8-K

Allarity Therapeutics Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250 Cambridge, MA U.S.A. - Allarity Therapeutics, Inc. , a clinical-stage. | April 22, 2022

United statesUnited kingdomThomas pedersenChuck padalaJens knudsenCompany contactCarrotize pr communicationsNasdaq hearings panelExchange commissionAllarity therapeutics incSmerud medical research internationalAllarity therapeutics receives nasdaqListing ruleListing qualifications departmentNasdaq stock marketNasdaq listing rule